BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
45.95
+1.14 (2.54%)
Aug 7, 2025, 4:00 PM - Market closed

Endeavor Group Holdings Statistics

Total Valuation

BBIO has a market cap or net worth of $8.78 billion. The enterprise value is $9.89 billion.

Market Cap8.78B
Enterprise Value 9.89B

Important Dates

The last earnings date was Tuesday, August 5, 2025, after market close.

Earnings Date Aug 5, 2025
Ex-Dividend Date n/a

Share Statistics

BBIO has 191.17 million shares outstanding. The number of shares has increased by 7.74% in one year.

Current Share Class 191.17M
Shares Outstanding 191.17M
Shares Change (YoY) +7.74%
Shares Change (QoQ) +0.20%
Owned by Insiders (%) 4.87%
Owned by Institutions (%) 77.48%
Float 149.99M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 36.96
Forward PS 19.63
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 41.92
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.19

Current Ratio 5.19
Quick Ratio 4.74
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -4.74

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -41.96%
Return on Invested Capital (ROIC) -108.17%
Return on Capital Employed (ROCE) -69.58%
Revenue Per Employee $323,030
Profits Per Employee -$1.06M
Employee Count730
Asset Turnover 0.25
Inventory Turnover n/a

Taxes

In the past 12 months, BBIO has paid $3.25 million in taxes.

Income Tax 3.25M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +84.76% in the last 52 weeks. The beta is 1.23, so BBIO's price volatility has been higher than the market average.

Beta (5Y) 1.23
52-Week Price Change +84.76%
50-Day Moving Average 43.06
200-Day Moving Average 34.22
Relative Strength Index (RSI) 51.91
Average Volume (20 Days) 2,964,618

Short Selling Information

The latest short interest is 19.48 million, so 10.19% of the outstanding shares have been sold short.

Short Interest 19.48M
Short Previous Month 21.83M
Short % of Shares Out 10.19%
Short % of Float 12.98%
Short Ratio (days to cover) 5.61

Income Statement

In the last 12 months, BBIO had revenue of $235.81 million and -$776.42 million in losses. Loss per share was -$4.09.

Revenue235.81M
Gross Profit 226.84M
Operating Income -629.24M
Pretax Income -453.82M
Net Income -776.42M
EBITDA -623.73M
EBIT -629.24M
Loss Per Share -$4.09
Full Income Statement

Balance Sheet

The company has $756.89 million in cash and $1.86 billion in debt, giving a net cash position of -$1.10 billion or -$5.76 per share.

Cash & Cash Equivalents 756.89M
Total Debt 1.86B
Net Cash -1.10B
Net Cash Per Share -$5.76
Equity (Book Value) -1.78B
Book Value Per Share -9.35
Working Capital 736.42M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$655.81 million and capital expenditures -$778,000, giving a free cash flow of -$656.59 million.

Operating Cash Flow -655.81M
Capital Expenditures -778,000
Free Cash Flow -656.59M
FCF Per Share -$3.43
Full Cash Flow Statement

Margins

Gross Margin 96.19%
Operating Margin -266.84%
Pretax Margin -331.52%
Profit Margin n/a
EBITDA Margin -264.50%
EBIT Margin -266.84%
FCF Margin n/a

Dividends & Yields

BBIO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -7.74%
Shareholder Yield -7.74%
Earnings Yield -8.84%
FCF Yield -7.47%
Dividend Details

Analyst Forecast

The average price target for BBIO is $61.69, which is 34.26% higher than the current price. The consensus rating is "Strong Buy".

Price Target $61.69
Price Target Difference 34.26%
Analyst Consensus Strong Buy
Analyst Count 16
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

BBIO has an Altman Z-Score of -4.14 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -4.14
Piotroski F-Score 2